Literature DB >> 26530325

MicroRNA-148b targets Rho-associated protein kinase 1 to inhibit cell proliferation, migration and invasion in hepatocellular carcinoma.

Xian Chen1, Lianhua Bo1, Wei Lu1, Guihua Zhou1, Qi Chen1.   

Abstract

microRNA(miR)-148b has been found to be downregulated in various human malignancies, including hepatocellular carcinoma (HCC) as well as gastric, pancreatic, colon and oral cancer. However, the function of miR‑148b in HCC has remained elusive. The present study examined the effects of miR‑148b on the proliferation, migration and invasion of HCC cells in vitro. After transfection of the HepG2 and SMMC‑7721 HCC cell lines with miR‑148b, an MTT assay, a Transwell migration and invasion assay as well as western blot analysis were performed. miR-148b was shown to inhibit cell proliferation, migration and invasion in the two cell lines. Using a luciferase reporter assay, the present study also provided the first evidence that miR‑148b directly targets Rho‑associated protein kinase 1 in HCC. These results suggested that miR-148 may represent a novel molecular marker and a potential molecular therapeutic for inhibiting metastasis of HCC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26530325     DOI: 10.3892/mmr.2015.4500

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

1.  MicroRNA-204 suppressed proliferation and motility capacity of human hepatocellular carcinoma via directly targeting zinc finger E-box binding homeobox 2.

Authors:  Bin Hu; Ming Sun; Jiajun Liu; Guolin Hong; Qin Lin
Journal:  Oncol Lett       Date:  2017-03-24       Impact factor: 2.967

2.  MicroRNA-129-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting DNMT3A.

Authors:  Xuhui Gu; Hui Gong; Lili Shen; Qingfeng Gu
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

3.  Transition from physical activity to inactivity increases skeletal muscle miR-148b content and triggers insulin resistance.

Authors:  Caroline Gastebois; Stéphanie Chanon; Sophie Rome; Christine Durand; Elise Pelascini; Audrey Jalabert; Vanessa Euthine; Vincent Pialoux; Stéphane Blanc; Chantal Simon; Etienne Lefai
Journal:  Physiol Rep       Date:  2016-09

Review 4.  Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis.

Authors:  Tomasz M Grzywa; Klaudia Klicka; Paweł K Włodarski
Journal:  Cancers (Basel)       Date:  2020-12-10       Impact factor: 6.639

5.  Apigenin Inhibits the Growth of Hepatocellular Carcinoma Cells by Affecting the Expression of microRNA Transcriptome.

Authors:  Shou-Mei Wang; Pei-Wei Yang; Xiao-Jun Feng; Yi-Wei Zhu; Feng-Jun Qiu; Xu-Dong Hu; Shu-Hui Zhang
Journal:  Front Oncol       Date:  2021-04-06       Impact factor: 6.244

Review 6.  Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma.

Authors:  Mohamed H Yousef; Hassan A N El-Fawal; Anwar Abdelnaser
Journal:  Biomed Res Int       Date:  2020-11-24       Impact factor: 3.411

7.  miRNA-411 acts as a potential tumor suppressor miRNA via the downregulation of specificity protein 1 in breast cancer.

Authors:  Liangfeng Guo; Jianhui Yuan; Ni Xie; Huisheng Wu; Weicai Chen; Shufen Song; Xianming Wang
Journal:  Mol Med Rep       Date:  2016-08-19       Impact factor: 2.952

8.  miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.

Authors:  Xiaowei Li; Mingzuo Jiang; Di Chen; Bing Xu; Rui Wang; Yi Chu; Weijie Wang; Lin Zhou; Zhijie Lei; Yongzhan Nie; Daiming Fan; Yulong Shang; Kaichun Wu; Jie Liang
Journal:  J Exp Clin Cancer Res       Date:  2018-03-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.